nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Central nervous system distributional kinetics of selected histone deacetylase inhibitors
|
Zhang, Wenqiu |
|
|
392 |
1 |
p. |
artikel |
2 |
Clinical development of the GluN2B-selective NMDA receptor inhibitor NP10679 for the treatment of neurologic deficit after subarachnoid hemorrhage
|
Wang, Haichen |
|
|
392 |
1 |
p. |
artikel |
3 |
Contrasting the reinforcing effects of the novel dopamine transport inhibitors JJC8-088 and JJC8-091 in monkeys: Potential translation to medication assisted treatment
|
Allen, Mia I. |
|
|
392 |
1 |
p. |
artikel |
4 |
Cover
|
|
|
|
392 |
1 |
p. |
artikel |
5 |
Deletion of PTP4A3 phosphatase in high-grade serous ovarian cancer cells decreases tumorigenicity and produces marked changes in intracellular signaling pathways and cytokine release
|
Lazo, John S. |
|
|
392 |
1 |
p. |
artikel |
6 |
Discovery of aurovertin B as a potent metastasis inhibitor against triple-negative breast cancer: Elucidating the complex role of the ATF3-DUSP1 axis
|
Shen, Jian-Jun |
|
|
392 |
1 |
p. |
artikel |
7 |
Does the drug enter the brain? If so, how much?
|
Hammarlund-Udenaes, Margareta |
|
|
392 |
1 |
p. |
artikel |
8 |
Efficacy of fluoxetine and (R,S)-ketamine in attenuating conditioned fear behaviors in male mice
|
Wells, Megan |
|
|
392 |
1 |
p. |
artikel |
9 |
Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder
|
Miller, Claire E. |
|
|
392 |
1 |
p. |
artikel |
10 |
Evaluation of systemic and brain pharmacokinetic parameters for repurposing metformin using intravenous bolus administration
|
Sharma, Sejal |
|
|
392 |
1 |
p. |
artikel |
11 |
Evidence for cytoprotective autophagy in response to HER2-targeted monoclonal antibodies
|
Elshazly, Ahmed M. |
|
|
392 |
1 |
p. |
artikel |
12 |
Innovation through imitation: IL-33 decoys show promise in pulmonary fibrosis
|
Kotas, Maya E. |
|
|
392 |
1 |
p. |
artikel |
13 |
Interrogating a compound library in search of an inhibitor for TREM-like transcript-1 to fibrinogen binding
|
Acsiniuc, Andrea |
|
|
392 |
1 |
p. |
artikel |
14 |
Mechanisms and management of thrombosis in cancer: Focus on gastrointestinal malignancies
|
Monegatti, Simone |
|
|
392 |
1 |
p. |
artikel |
15 |
Metformin finding its way into the central nervous system: Combating neurological diseases?
|
Cignarella, Andrea |
|
|
392 |
1 |
p. |
artikel |
16 |
Metformin in overcoming enzalutamide resistance in castration-resistant prostate cancer
|
Simpson, Kendall |
|
|
392 |
1 |
p. |
artikel |
17 |
New potential ligand-receptor axis involved in tissue repair as therapeutic targets in progressive multiple sclerosis
|
Carrera Silva, Eugenio Antonio |
|
|
392 |
1 |
p. |
artikel |
18 |
NOSH-aspirin (NBS-1120) inhibits estrogen receptor–negative breast cancer in vitro and in vivo by modulating redox-sensitive signaling pathways
|
Chattopadhyay, Mitali |
|
|
392 |
1 |
p. |
artikel |
19 |
Oklahoma nitrone-007 is an effective anticancer therapeutic agent targeting inflammatory and immune metabolism pathways in endometrial cancer
|
Elayapillai, Sugantha Priya |
|
|
392 |
1 |
p. |
artikel |
20 |
Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet function
|
Zhang, Yiheng |
|
|
392 |
1 |
p. |
artikel |
21 |
Platelet spreading and clot retraction are regulated by 2 distinct α IIb β 3 outside-in signaling pathways
|
Nigam, Arjit |
|
|
392 |
1 |
p. |
artikel |
22 |
Preclinical evaluation of MK-8189: A novel phosphodiesterase 10A inhibitor for the treatment of schizophrenia
|
Smith, Sean M. |
|
|
392 |
1 |
p. |
artikel |
23 |
Protease-activated receptor 2: A promising therapeutic target for women’s cancers
|
Shah, Himani |
|
|
392 |
1 |
p. |
artikel |
24 |
Quantification of cinpanemab (BIIB054) binding to α-synuclein in cerebrospinal fluid of phase 1 single ascending dose samples
|
Liu, YuTing |
|
|
392 |
1 |
p. |
artikel |
25 |
Special section on Breaking Barriers in Women's Cancer Treatment: Innovative Approaches and Experimental Therapeutics—Editorial
|
Yeh, Elizabeth |
|
|
392 |
1 |
p. |
artikel |
26 |
The elucidation of species-specific receptor pharmacology: A case study using subtype-selective para- and meta-carborane estrogen receptor agonists
|
Adeluola, Adeoluwa A. |
|
|
392 |
1 |
p. |
artikel |
27 |
The protective effect of amitriptyline on experimental colitis through inhibiting TLR-4/MD-2 signaling pathway
|
Zeng, Chengcheng |
|
|
392 |
1 |
p. |
artikel |
28 |
The protective effect of irisin against hemorrhagic injury is mediated by PI3K and p38 pathways in hemorrhage/resuscitation
|
Wen, Huai |
|
|
392 |
1 |
p. |
artikel |
29 |
Therapeutic targeting of full-length interleukin-33 protein levels with cell-permeable decoy peptides attenuates fibrosis in the bleomycin model in vivo
|
Atamas, Sergei P. |
|
|
392 |
1 |
p. |
artikel |
30 |
VERU-111, an orally available tubulin inhibitor, suppresses ovarian tumor growth and metastasis
|
Waddell, Shelby |
|
|
392 |
1 |
p. |
artikel |
31 |
Zero-length crosslinking: A breakthrough approach for evaluating target engagement in α-synuclein immunotherapy
|
Rochet, Jean-Christophe |
|
|
392 |
1 |
p. |
artikel |